1999
DOI: 10.1126/science.283.5402.682
|View full text |Cite
|
Sign up to set email alerts
|

Transduction of Human CD34 + Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors

Abstract: Efficient gene transfer into human hematopoietic stem cells (HSCs) is an important goal in the study of the hematopoietic system as well as for gene therapy of hematopoietic disorders. A lentiviral vector based on the human immunodeficiency virus (HIV) was able to transduce human CD34+ cells capable of stable, long-term reconstitution of nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. High-efficiency transduction occurred in the absence of cytokine stimulation and resulted in transgene expre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

14
391
0
4

Year Published

2000
2000
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 622 publications
(411 citation statements)
references
References 33 publications
(7 reference statements)
14
391
0
4
Order By: Relevance
“…Similar considerations apply to the use of lentiviral vectors, which are often used at a very high MOI in preclinical models. 32,33 In the present study, transduction of murine hematopoietic cells with controlled MOI was helpful to demonstrate the substantial impact of the stability of the transgenic protein on vector performance, an issue that has not been addressed previously. A long half-life of a therapeutic protein expressed from a retroviral vector in hematopoietic cells may be of particular relevance for the correction of a large number of genetic disorders affecting long-lived mature blood cells, such as macrophages, T cells, or erythrocytes.…”
Section: Gene Therapymentioning
confidence: 91%
“…Similar considerations apply to the use of lentiviral vectors, which are often used at a very high MOI in preclinical models. 32,33 In the present study, transduction of murine hematopoietic cells with controlled MOI was helpful to demonstrate the substantial impact of the stability of the transgenic protein on vector performance, an issue that has not been addressed previously. A long half-life of a therapeutic protein expressed from a retroviral vector in hematopoietic cells may be of particular relevance for the correction of a large number of genetic disorders affecting long-lived mature blood cells, such as macrophages, T cells, or erythrocytes.…”
Section: Gene Therapymentioning
confidence: 91%
“…In cell types of the haematopoietic system, mature cells have been modified by viral infection of progenitor cells that undergo differentiation. Several groups have recently reported successful transduction of reporter genes or genes of therapeutical importance into progenitor cells that were taken from umbilical cord blood or bone marrow and differentiated into mature cells [12][13][14][15]. In these experiments, the transgene was constitutively expressed, irrespective of the differentiation stage.…”
Section: Introductionmentioning
confidence: 99%
“…Vectors based on the lentivirus HIV-1 are effective in transducing human lymphocytes, 5 myeloid cells, 6 hematopoietic progenitor, 7 and NOD/SCID repopulating cells. 8 Optimization of HIV-1 vectors using self-inactivating LTRs, a variety of viral, cellular and hematopoietic cell type specific promoters, post-transcriptional elements, and insulator sequences have further improved transduction and expression of these vectors in hematopoietic cells (reviewed in Hawley 9 ).…”
Section: Introductionmentioning
confidence: 99%